Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

ClinicalTrials.gov ID: NCT00067158

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00067158. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:18 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Study identification

NCT ID: NCT00067158
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: New York University; Other
Enrollment: 585 participants

Conditions and interventions

Conditions

Tobacco Use Disorder

Interventions

nicotine transdermal system Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 99 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2003 (Type not available)
Primary completion: Jul 2004 (Actual)
Completion: Jul 2004 (Actual)
Last update posted: Jan 12, 2017

2003 – 2004

United States locations

U.S. sites: 13
U.S. states: 6
U.S. cities: 11

Facility	City	State	ZIP	Site status
Matrix Institute on Addictions	Los Angeles	California	90016	—
Tarzana Treatment Center	Tarzana	California	91356	—
SPECTRUM	Miami	Florida	33156	—
Center for Drug Free Living	Orlando	Florida	32805	—
Chelsea Arbor Addictions Treatment Center	Ann Arbor	Michigan	48103	—
Psychiatry and Behavioral Medicine Professionals I	Detroit	Michigan	48207	—
Narco Freedom (Bridge Plaza)	Long Island City	New York	11101	—
St. Luke's Roosevelt Hospital Center	New York	New York	10019	—
St. Luke's Roosevelt Hospital Center, Womens	New York	New York	10025	—
Mount Sinai Medical Center	New York	New York	10029	—
Piedmont Behavioral Healthcare	Concord	North Carolina	28001	—
Coastal Horizons Center, Inc.	Wilmington	North Carolina	28412	—
Behavioral Health Services of Pickens County	Pickens	South Carolina	29671	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00067158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 12, 2017 · Synced Nov 15, 2026